15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study.
Lai B, Mei C, Yan X, Chen L, Wang Y, Sheng L, Tang S, Mao L, Zhang P, Sun Y, Xie W, Zhou D, Mai W, Wang H, Ma L, Lou Y, Wu W, Jiang H, Zhang J, Ye B, Tong H, Ouyang G.
Lai B, et al. Among authors: lou y.
Cancers (Basel). 2026 Jan 2;18(1):159. doi: 10.3390/cancers18010159.
Cancers (Basel). 2026.
PMID: 41514667
Free PMC article.